Using Low-Intensity Electric Fields as a Form of Cancer Therapy

Bill Doyle of Novocure, a company that developed non-invasive technology to control cell division in glioblastoma tumors, spoke at TEDMED 2012 about the role low-intensity alternating electric fields can have on cancer therapy:


This post also appears on medGadget, an Atlantic partner site.

Presented by

medGadget is written by a group of MDs and biomedical engineers.

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register with Disqus.

Please note that The Atlantic's account system is separate from our commenting system. To log in or register with The Atlantic, use the Sign In button at the top of every page.

blog comments powered by Disqus